SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - Politician Trades

Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SNSE stock?

Rallies tracks politician and congressional stock disclosures for SNSE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

SNSE Key Metrics

Key financial metrics for SNSE
MetricValue
Price$17.58
Market Cap$26.70M
P/E Ratio-1.04
EPS$-16.72
Dividend Yield0.00%
52-Week High$36.76
52-Week Low$5.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-21.09M
Gross Margin0.00%

Latest SNSE News

Recent SNSE Insider Trades

  • MILLENNIUM MANAGEMENT LLC bought 1.11K (~$36.99K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 2.12K (~$61.21K) on Apr 7, 2026.
  • MILLENNIUM MANAGEMENT LLC sold 205 (~$6.09K) on Apr 7, 2026.

SNSE Analyst Consensus

SNSE analyst coverage data. Average price target: $0.00.

Common questions about SNSE

Which politicians traded SNSE stock?
Rallies tracks politician and congressional stock disclosures for SNSE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SNSE?
Yes. Rallies tracks politician and congressional stock disclosures for SNSE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SNSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNSE. It does not provide personalized investment advice.
SNSE

SNSE